Immuneering Corp. (IMRX)
3.73
-0.08
(-2.10%)
USD |
NASDAQ |
Oct 23, 16:00
3.725
0.00 (0.00%)
After-Hours: 20:00
Immuneering Price to Book Value : 1.265 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 1.265 |
| October 22, 2026 | 1.292 |
| October 21, 2026 | 1.269 |
| October 20, 2026 | 1.265 |
| October 19, 2026 | 1.242 |
| October 16, 2026 | 1.218 |
| October 15, 2026 | 1.235 |
| October 14, 2026 | 1.160 |
| October 13, 2026 | 1.208 |
| October 12, 2026 | 1.309 |
| October 09, 2026 | 1.336 |
| October 08, 2026 | 1.269 |
| October 07, 2026 | 1.309 |
| October 06, 2026 | 1.299 |
| October 05, 2026 | 1.370 |
| October 02, 2026 | 1.380 |
| October 01, 2026 | 1.367 |
| September 30, 2026 | 1.389 |
| September 29, 2026 | 1.401 |
| September 28, 2026 | 1.411 |
| September 25, 2026 | 1.448 |
| September 24, 2026 | 1.472 |
| September 23, 2026 | 1.486 |
| September 22, 2026 | 1.564 |
| September 21, 2026 | 1.506 |
| Date | Value |
|---|---|
| September 18, 2026 | 1.520 |
| September 17, 2026 | 1.513 |
| September 16, 2026 | 1.509 |
| September 15, 2026 | 1.506 |
| September 14, 2026 | 1.469 |
| September 11, 2026 | 1.448 |
| September 10, 2026 | 1.550 |
| September 09, 2026 | 1.564 |
| September 08, 2026 | 1.621 |
| September 04, 2026 | 1.635 |
| September 03, 2026 | 1.710 |
| September 02, 2026 | 1.703 |
| September 01, 2026 | 1.645 |
| August 31, 2026 | 1.693 |
| August 28, 2026 | 1.693 |
| August 27, 2026 | 1.767 |
| August 26, 2026 | 1.747 |
| August 25, 2026 | 1.774 |
| August 24, 2026 | 1.757 |
| August 21, 2026 | 1.798 |
| August 20, 2026 | 1.781 |
| August 19, 2026 | 1.808 |
| August 18, 2026 | 1.706 |
| August 17, 2026 | 1.771 |
| August 14, 2026 | 1.716 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.599 |
| Alnylam Pharmaceuticals, Inc. | 22.13 |
| Anika Therapeutics, Inc. | 2.088 |
| Savara, Inc. | 6.034 |
| Vericel Corp. | 5.881 |
Price to Book Value Related Metrics
| Price | 3.73 |
| Earnings Yield | -27.66% |
| Market Cap | 241.32M |